Histochemical examination of osteoblastic activity in op/op mice with or without injection of recombinant M-CSF
- PMID: 11498728
- DOI: 10.1007/s007740170010
Histochemical examination of osteoblastic activity in op/op mice with or without injection of recombinant M-CSF
Abstract
Osteopetrotic (op/op) mice do not exhibit bone remodeling because of defective osteoclast formation caused by the depletion of macrophage colony-stimulating factor (M-CSF). In the present study, we investigated tibial bones of op/op mice with or without prior injections of M-CSF to determine whether osteoclast formation and subsequent bone resorption could activate osteoblasts, which is known as a "coupling" phenomenon. In op/op mice, no osteoclasts were present, but the metaphyseal osteoblasts adjacent to the growth plate cartilage seemed to be active, revealing an intense alkaline phosphatase (ALPase) immunoreactivity. Consequently, primary trabecular bones were extended continuously to the diaphysis, indicating that bone modeling is well achieved in op/op mice. In contrast with the metaphysis, most of the diaphyseal osteoblasts were flattened and showed weak ALPase activity, and, as a result, they seemed to be less active. Osteopontin (OPN) was localized slightly at the interface between bone and cartilage matrices of the primary trabeculae. In contrast, in op/op mice injected with M-CSF, tartrate-resistant acid phosphatase-positive osteoclasts appeared, resorbing trabecular bones of the diaphyseal region. The diaphyseal osteoblasts in the vicinity of the active osteoclasts were cuboidal and exhibited strong ALPase immunoreactivity. OPN was observed not only at the bone-cartilage interface, but also significantly on the resorption lacunae beneath the bone-resorbing osteoclasts. These observations indicate that the activation of diaphyseal osteoblasts appears to be coupled with osteoclast formation and subsequent osteoclastic bone resorption. Alternatively, the metaphyseal osteoblasts at the chondro-osseous junction seemed to be less affected by osteoclastic activity.
Similar articles
-
Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice.Micron. 2005;36(7-8):688-95. doi: 10.1016/j.micron.2005.06.008. Epub 2005 Sep 7. Micron. 2005. PMID: 16182547
-
Treatment with recombinant human macrophage colony-stimulating factor resorbs blood clot and restores osteoclastogenesis in heterotopic bone induced by partially purified native bone morphogenetic protein in osteopetrotic (op/op) mice.J Orthop Res. 1997 May;15(3):456-62. doi: 10.1002/jor.1100150320. J Orthop Res. 1997. PMID: 9246094
-
Osteoclastic activity induces osteomodulin expression in osteoblasts.Biochem Biophys Res Commun. 2007 Oct 19;362(2):460-6. doi: 10.1016/j.bbrc.2007.07.193. Epub 2007 Aug 13. Biochem Biophys Res Commun. 2007. PMID: 17714690
-
Role of CSF-1 in bone and bone marrow development.Mol Reprod Dev. 1997 Jan;46(1):75-83; discussion 83-4. doi: 10.1002/(SICI)1098-2795(199701)46:1<75::AID-MRD12>3.0.CO;2-2. Mol Reprod Dev. 1997. PMID: 8981367 Review.
-
Alkaline phosphatase and tartrate-resistant acid phosphatase in osteoblasts of normal and pathologic bone.Ital J Anat Embryol. 2001;106(2 Suppl 1):129-33. Ital J Anat Embryol. 2001. PMID: 11729947 Review.
Cited by
-
Localization of Minodronate in Mouse Femora Through Isotope Microscopy.J Histochem Cytochem. 2016 Oct;64(10):601-22. doi: 10.1369/0022155416665577. J Histochem Cytochem. 2016. PMID: 27666429 Free PMC article.
-
Histological evaluation for "bone quality" on two mouse models with different bone remodeling.J Bone Miner Metab. 2005;23 Suppl:43-7. doi: 10.1007/BF03026322. J Bone Miner Metab. 2005. PMID: 15984413 No abstract available.
-
Effects of drug discontinuation after short-term daily alendronate administration on osteoblasts and osteocytes in mice.Histochem Cell Biol. 2016 Sep;146(3):337-50. doi: 10.1007/s00418-016-1450-7. Epub 2016 May 27. Histochem Cell Biol. 2016. PMID: 27235014
-
Administration of high-dose macrophage colony-stimulating factor increases bone turnover and trabecular volume fraction.J Bone Miner Metab. 2009;27(5):546-54. doi: 10.1007/s00774-009-0071-9. Epub 2009 Mar 27. J Bone Miner Metab. 2009. PMID: 19326045
-
Increased bone mass but delayed mineralization: in vivo and in vitro study for zoledronate in bone regeneration.BMC Oral Health. 2024 Sep 27;24(1):1146. doi: 10.1186/s12903-024-04906-2. BMC Oral Health. 2024. PMID: 39334089 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous